insights_auto
Kwa nini CSJA imepungua kwa 4.17%?
Fahamu zaidichevron_right
CSJA:FRA
CSL ADR
€ 27.60
arrow_downward
-4.17%(-1.20) Siku 1
18 Nov, 08:06:43 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya CSJA...
Fungua
€ 27.60
Juu
€ 27.60
Chini
€ 27.60
Mtaji wa soko
95.68B
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
40.00
Juu kwa wiki 52
€ 43.40
Chini kwa wiki 52
€ 12.70
Idadi ya wafanyakazi
elfu 29
Fungua
€ 27.60
Juu
€ 27.60
Chini
€ 27.60
Mtaji wa soko
95.68B
Wastani wa kiasi cha mauzo
0.00
Kiasi cha mauzo ya hisa
40.00
Juu kwa wiki 52
€ 43.40
Chini kwa wiki 52
€ 12.70
Idadi ya wafanyakazi
elfu 29
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Kalkine
·
saa 3 zilizopita
CSL (ASX:CSL) Shares Gain 11% Over a Year. What Should Investors Watch in the Restructuring?
The Motley Fool Australia
·
saa 14 zilizopita
At $199, are CSL shares a bargain buy or a risky investment?
Yahoo Finance Australia
·
saa 15 zilizopita
CSL’s MV Yampu Named 2026 Bulk Ship of the Year at IBJ Awards
Wasifu
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
Kuhusu CSL ADR
Afisa Mkuu Mtendaji (CEO)Paul McKenzie
Wafanyakazielfu 29
Lilianzishwa1916
Makao makuuMelbourne, Victoria, Australia
SektaHealth Care
Sekta-
Tovuticsl.com